Blood test could spot rare cancer in NF1 patients before symptoms show
Knowledge-focused
Recruiting now
This study looks at whether a blood test (liquid biopsy) can detect a rare cancer called MPNST earlier than current methods in 1,000 adults with Neurofibromatosis Type 1 (NF1) who have had benign nerve tumors. Participants give blood samples and answer surveys every six months fo…
Sponsor: David Miller • Aim: Knowledge-focused
Last updated May 07, 2026 11:46 UTC